Oral

Fusobacterium nucleatum Porphyromonas gingivalis atherosclerosis cardiovascular disease heterozygous familial hypercholesterolemia secondary cardiovascular prevention

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
31 Aug 2022
Historique:
received: 26 07 2022
revised: 24 08 2022
accepted: 26 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

Low-grade chronic inflammation, promoted by dysbiosis of the gut and oral microbiota, has been shown to contribute to individual susceptibility to atherosclerotic cardiovascular disease (ASCVD). High oral In this cross-sectional study, 40 patients with previously diagnosed ASCVD (10 with genetically proven HeFH, and 30 without FH), 26 subjects with HeFH in primary prevention, and 31 healthy subjects were selected to quantify oral Compared to healthy subjects, patients with previously diagnosed ASCVD showed greater Greater oral

Sections du résumé

BACKGROUND BACKGROUND
Low-grade chronic inflammation, promoted by dysbiosis of the gut and oral microbiota, has been shown to contribute to individual susceptibility to atherosclerotic cardiovascular disease (ASCVD). High oral
METHODS METHODS
In this cross-sectional study, 40 patients with previously diagnosed ASCVD (10 with genetically proven HeFH, and 30 without FH), 26 subjects with HeFH in primary prevention, and 31 healthy subjects were selected to quantify oral
RESULTS RESULTS
Compared to healthy subjects, patients with previously diagnosed ASCVD showed greater
CONCLUSIONS CONCLUSIONS
Greater oral

Identifiants

pubmed: 36140246
pii: biomedicines10092144
doi: 10.3390/biomedicines10092144
pmc: PMC9496065
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Front Cell Infect Microbiol. 2021 Jan 19;10:580577
pubmed: 33542905
J Periodontol. 1967 Nov-Dec;38(6):Suppl:610-6
pubmed: 5237684
PLoS One. 2011;6(5):e20240
pubmed: 21625524
Int J Mol Sci. 2020 Jun 23;21(12):
pubmed: 32585928
Cardiol Clin. 2015 May;33(2):169-79
pubmed: 25939291
Cancers (Basel). 2021 Mar 01;13(5):
pubmed: 33804585
Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1405-11
pubmed: 12816879
Clin Exp Dent Res. 2021 Feb;7(1):109-122
pubmed: 33124761
Eur J Immunol. 2018 Apr;48(4):564-575
pubmed: 29230812
Eur J Oral Sci. 2022 Feb;130(1):e12829
pubmed: 34874583
Infect Immun. 2015 Dec;83(12):4582-93
pubmed: 26371120
Br J Pharmacol. 2018 Dec;175(24):4439-4449
pubmed: 30129122
J Thorac Dis. 2018 Jan;10(1):64-69
pubmed: 29600023
Postgrad Med J. 2017 Apr;93(1098):215-220
pubmed: 27899684
Mech Ageing Dev. 2021 Apr;195:111467
pubmed: 33711349
Anaerobe. 2021 Oct;71:102399
pubmed: 34090994
Clin Exp Dent Res. 2021 Dec;7(6):1080-1088
pubmed: 34041870
PLoS One. 2015 Jun 16;10(6):e0129795
pubmed: 26079509
Mol Oral Microbiol. 2012 Apr;27(2):109-23
pubmed: 22394469
J Dent Res. 2013 Mar;92(3):241-6
pubmed: 23318766
J Clin Periodontol. 2016 Dec;43(12):1003-1012
pubmed: 27717180
J Periodontal Res. 2022 Jun;57(3):479-486
pubmed: 35293616
Circ Res. 2017 Mar 31;120(7):1183-1196
pubmed: 28360349
Clin Oral Investig. 2022 Jan;26(1):535-542
pubmed: 34180000
Genome Med. 2016 Apr 20;8(1):42
pubmed: 27098727
Int J Mol Sci. 2019 Jun 15;20(12):
pubmed: 31208079
Biomed Pharmacother. 2017 May;89:918-925
pubmed: 28292019
Biomolecules. 2021 Oct 28;11(11):
pubmed: 34827594
Biomolecules. 2021 Jun 06;11(6):
pubmed: 34204019
Int J Cardiol. 2016 Jan 15;203:1044-51
pubmed: 26638053
Innate Immun. 2012 Feb;18(1):164-70
pubmed: 21239459
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725
pubmed: 31301983
PLoS One. 2017 Apr 3;12(4):e0174782
pubmed: 28369125
Eur J Oral Sci. 2018 Oct;126 Suppl 1:26-36
pubmed: 30178551
Atheroscler Suppl. 2017 Oct;29:11-16
pubmed: 28965615
Front Immunol. 2021 Dec 23;12:766560
pubmed: 35003080
J Clin Biochem Nutr. 2015 Sep;57(2):135-9
pubmed: 26388671
Nature. 2020 May;581(7808):310-315
pubmed: 32433607
Eur Heart J. 2017 Aug 21;38(32):2459-2472
pubmed: 28444290
PLoS One. 2013 Aug 16;8(8):e71849
pubmed: 23977160
Rev Cardiovasc Med. 2019 Jun 30;20(2):81-89
pubmed: 31345000
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4592-8
pubmed: 20937873
J Lipid Res. 2004 Jan;45(1):139-47
pubmed: 13130123
Front Microbiol. 2018 Oct 24;9:2470
pubmed: 30405551
Atherosclerosis. 2018 Oct;277:457-463
pubmed: 30270085
Int J Cardiol. 2011 Apr 14;148(2):148-53
pubmed: 19913930
Lancet. 2021 Nov 6;398(10312):1713-1725
pubmed: 34506743
J Clin Diagn Res. 2017 Sep;11(9):ZC17-ZC21
pubmed: 29207826
Ann N Y Acad Sci. 2009 Apr;1163:221-32
pubmed: 19456343
J Am Coll Cardiol. 2016 Jun 7;67(22):2578-89
pubmed: 27050191

Auteurs

Maria Cristina Curia (MC)

Department of Medical, Oral and Biotechnological Sciences, Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.

Pamela Pignatelli (P)

Department of Medical, Oral and Biotechnological Sciences, Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.
Department of Oral and Maxillofacial Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.

Domenica Lucia D'Antonio (DL)

Department of Medical, Oral and Biotechnological Sciences, Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.

Damiano D'Ardes (D)

Regional Center for the Study of Atherosclerosis, Hypertension and Dyslipidemia, "SS Annunziata" Hospital-ASL, 66100 Chieti, Italy.
C.A.S.T., Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.

Elena Olmastroni (E)

Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.

Luca Scorpiglione (L)

Regional Center for the Study of Atherosclerosis, Hypertension and Dyslipidemia, "SS Annunziata" Hospital-ASL, 66100 Chieti, Italy.
C.A.S.T., Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.

Francesco Cipollone (F)

Regional Center for the Study of Atherosclerosis, Hypertension and Dyslipidemia, "SS Annunziata" Hospital-ASL, 66100 Chieti, Italy.
C.A.S.T., Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.

Alberico Luigi Catapano (AL)

Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
IRCCS MultiMedica, Sesto S. Giovanni, 20099 Milan, Italy.

Adriano Piattelli (A)

Master Course in Microsurgery in Odontostomatology, Saint Camillus International University for Health Sciences (Unicamillus), 00131 Rome, Italy.
Fondazione Villaserena per la Ricerca, 65013 Città Sant'Angelo, Pescara, Italy.
Casa di Cura Villa Serena, 65013 Città Sant'Angelo, Pescara, Italy.

Marco Bucci (M)

Regional Center for the Study of Atherosclerosis, Hypertension and Dyslipidemia, "SS Annunziata" Hospital-ASL, 66100 Chieti, Italy.
C.A.S.T., Università degli Studi "Gabriele d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy.

Paolo Magni (P)

Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
IRCCS MultiMedica, Sesto S. Giovanni, 20099 Milan, Italy.

Classifications MeSH